nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—CACNA1A—Type II diabetes mellitus—PDX1—pancreatic cancer	0.00832	0.172	CbGpPWpGaD
Pregabalin—CACNA1A—Type II diabetes mellitus—SLC2A2—pancreatic cancer	0.00525	0.108	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00266	0.0551	CbGpPWpGaD
Pregabalin—CACNA1A—Regulation of insulin secretion—GLP1R—pancreatic cancer	0.00206	0.0426	CbGpPWpGaD
Pregabalin—CACNA1A—Regulation of insulin secretion—SLC2A2—pancreatic cancer	0.00193	0.0398	CbGpPWpGaD
Pregabalin—CACNA2D2—Regulation of insulin secretion—GLP1R—pancreatic cancer	0.00173	0.0357	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00166	0.0343	CbGpPWpGaD
Pregabalin—CACNA1A—Integration of energy metabolism—GLP1R—pancreatic cancer	0.00162	0.0335	CbGpPWpGaD
Pregabalin—CACNA2D2—Regulation of insulin secretion—SLC2A2—pancreatic cancer	0.00161	0.0334	CbGpPWpGaD
Pregabalin—CACNA1A—Integration of energy metabolism—SLC2A2—pancreatic cancer	0.00151	0.0313	CbGpPWpGaD
Pregabalin—CACNA1A—Regulation of insulin secretion—GCG—pancreatic cancer	0.00143	0.0296	CbGpPWpGaD
Pregabalin—CACNA2D2—Integration of energy metabolism—GLP1R—pancreatic cancer	0.00136	0.0281	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00135	0.028	CbGpPWpGaD
Pregabalin—CACNA2D2—Integration of energy metabolism—SLC2A2—pancreatic cancer	0.00127	0.0262	CbGpPWpGaD
Pregabalin—CACNA2D2—Regulation of insulin secretion—GCG—pancreatic cancer	0.0012	0.0248	CbGpPWpGaD
Pregabalin—CACNA1A—Type II diabetes mellitus—TNF—pancreatic cancer	0.00119	0.0245	CbGpPWpGaD
Pregabalin—CACNA1A—Integration of energy metabolism—GCG—pancreatic cancer	0.00112	0.0232	CbGpPWpGaD
Pregabalin—CACNA1A—Integration of energy metabolism—STK11—pancreatic cancer	0.00106	0.0219	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.00101	0.0208	CbGpPWpGaD
Pregabalin—CACNA2D2—Integration of energy metabolism—GCG—pancreatic cancer	0.000942	0.0195	CbGpPWpGaD
Pregabalin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—pancreatic cancer	0.000895	0.0185	CbGpPWpGaD
Pregabalin—CACNA2D2—Integration of energy metabolism—STK11—pancreatic cancer	0.000886	0.0183	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000511	0.0106	CbGpPWpGaD
Pregabalin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—pancreatic cancer	0.000499	0.0103	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PRSS1—pancreatic cancer	0.000304	0.00628	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ARG2—pancreatic cancer	0.000263	0.00544	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PRSS1—pancreatic cancer	0.000254	0.00526	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000236	0.00489	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—TYMP—pancreatic cancer	0.00023	0.00476	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ARG2—pancreatic cancer	0.000221	0.00456	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—TYMP—pancreatic cancer	0.000193	0.00399	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GLP1R—pancreatic cancer	0.000185	0.00383	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—DPYD—pancreatic cancer	0.000182	0.00377	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—HRAS—pancreatic cancer	0.000181	0.00374	CbGpPWpGaD
Pregabalin—Oedema—Docetaxel—pancreatic cancer	0.000176	0.000185	CcSEcCtD
Pregabalin—Weight increased—Doxorubicin—pancreatic cancer	0.000175	0.000184	CcSEcCtD
Pregabalin—Epistaxis—Epirubicin—pancreatic cancer	0.000175	0.000184	CcSEcCtD
Pregabalin—Pruritus—Gemcitabine—pancreatic cancer	0.000175	0.000184	CcSEcCtD
Pregabalin—Infection—Docetaxel—pancreatic cancer	0.000174	0.000183	CcSEcCtD
Pregabalin—Weight decreased—Doxorubicin—pancreatic cancer	0.000174	0.000183	CcSEcCtD
Pregabalin—Sinusitis—Epirubicin—pancreatic cancer	0.000174	0.000183	CcSEcCtD
Pregabalin—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000174	0.000183	CcSEcCtD
Pregabalin—Diarrhoea—Irinotecan—pancreatic cancer	0.000174	0.000183	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—SLC2A2—pancreatic cancer	0.000173	0.00358	CbGpPWpGaD
Pregabalin—Pneumonia—Doxorubicin—pancreatic cancer	0.000173	0.000182	CcSEcCtD
Pregabalin—Shock—Docetaxel—pancreatic cancer	0.000173	0.000182	CcSEcCtD
Pregabalin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000172	0.000181	CcSEcCtD
Pregabalin—Pruritus—Fluorouracil—pancreatic cancer	0.000172	0.000181	CcSEcCtD
Pregabalin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000172	0.000181	CcSEcCtD
Pregabalin—Infestation—Doxorubicin—pancreatic cancer	0.000172	0.000181	CcSEcCtD
Pregabalin—Infestation NOS—Doxorubicin—pancreatic cancer	0.000172	0.000181	CcSEcCtD
Pregabalin—Tachycardia—Docetaxel—pancreatic cancer	0.000171	0.00018	CcSEcCtD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000171	0.00353	CbGpPWpGaD
Pregabalin—Skin disorder—Docetaxel—pancreatic cancer	0.000171	0.000179	CcSEcCtD
Pregabalin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00017	0.000179	CcSEcCtD
Pregabalin—Bradycardia—Epirubicin—pancreatic cancer	0.00017	0.000178	CcSEcCtD
Pregabalin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000169	0.000178	CcSEcCtD
Pregabalin—Renal failure—Doxorubicin—pancreatic cancer	0.000169	0.000177	CcSEcCtD
Pregabalin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000168	0.000177	CcSEcCtD
Pregabalin—Dizziness—Irinotecan—pancreatic cancer	0.000168	0.000177	CcSEcCtD
Pregabalin—Haemoglobin—Epirubicin—pancreatic cancer	0.000168	0.000176	CcSEcCtD
Pregabalin—Stomatitis—Doxorubicin—pancreatic cancer	0.000167	0.000176	CcSEcCtD
Pregabalin—Jaundice—Doxorubicin—pancreatic cancer	0.000167	0.000176	CcSEcCtD
Pregabalin—Anorexia—Docetaxel—pancreatic cancer	0.000167	0.000176	CcSEcCtD
Pregabalin—Rhinitis—Epirubicin—pancreatic cancer	0.000167	0.000176	CcSEcCtD
Pregabalin—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000167	0.000176	CcSEcCtD
Pregabalin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000167	0.000176	CcSEcCtD
Pregabalin—Hepatitis—Epirubicin—pancreatic cancer	0.000167	0.000175	CcSEcCtD
Pregabalin—Haemorrhage—Epirubicin—pancreatic cancer	0.000167	0.000175	CcSEcCtD
Pregabalin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000166	0.000175	CcSEcCtD
Pregabalin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000166	0.000174	CcSEcCtD
Pregabalin—Pharyngitis—Epirubicin—pancreatic cancer	0.000165	0.000174	CcSEcCtD
Pregabalin—Sweating—Doxorubicin—pancreatic cancer	0.000165	0.000173	CcSEcCtD
Pregabalin—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000165	0.000173	CcSEcCtD
Pregabalin—Oedema peripheral—Epirubicin—pancreatic cancer	0.000164	0.000173	CcSEcCtD
Pregabalin—Hypotension—Docetaxel—pancreatic cancer	0.000164	0.000172	CcSEcCtD
Pregabalin—Haematuria—Doxorubicin—pancreatic cancer	0.000164	0.000172	CcSEcCtD
Pregabalin—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000164	0.000172	CcSEcCtD
Pregabalin—Urethral disorder—Epirubicin—pancreatic cancer	0.000163	0.000172	CcSEcCtD
Pregabalin—Epistaxis—Doxorubicin—pancreatic cancer	0.000162	0.00017	CcSEcCtD
Pregabalin—Vomiting—Irinotecan—pancreatic cancer	0.000162	0.00017	CcSEcCtD
Pregabalin—Sinusitis—Doxorubicin—pancreatic cancer	0.000161	0.000169	CcSEcCtD
Pregabalin—Dizziness—Fluorouracil—pancreatic cancer	0.000161	0.000169	CcSEcCtD
Pregabalin—Visual impairment—Epirubicin—pancreatic cancer	0.000161	0.000169	CcSEcCtD
Pregabalin—Rash—Irinotecan—pancreatic cancer	0.00016	0.000168	CcSEcCtD
Pregabalin—Dermatitis—Irinotecan—pancreatic cancer	0.00016	0.000168	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00016	0.000168	CcSEcCtD
Pregabalin—Headache—Irinotecan—pancreatic cancer	0.000159	0.000167	CcSEcCtD
Pregabalin—Insomnia—Docetaxel—pancreatic cancer	0.000159	0.000167	CcSEcCtD
Pregabalin—Paraesthesia—Docetaxel—pancreatic cancer	0.000158	0.000166	CcSEcCtD
Pregabalin—Erythema multiforme—Epirubicin—pancreatic cancer	0.000158	0.000166	CcSEcCtD
Pregabalin—Vomiting—Gemcitabine—pancreatic cancer	0.000157	0.000165	CcSEcCtD
Pregabalin—Bradycardia—Doxorubicin—pancreatic cancer	0.000157	0.000165	CcSEcCtD
Pregabalin—Dyspnoea—Docetaxel—pancreatic cancer	0.000157	0.000165	CcSEcCtD
Pregabalin—Somnolence—Docetaxel—pancreatic cancer	0.000156	0.000164	CcSEcCtD
Pregabalin—Rash—Gemcitabine—pancreatic cancer	0.000156	0.000164	CcSEcCtD
Pregabalin—Dermatitis—Gemcitabine—pancreatic cancer	0.000156	0.000164	CcSEcCtD
Pregabalin—Eye disorder—Epirubicin—pancreatic cancer	0.000156	0.000164	CcSEcCtD
Pregabalin—Tinnitus—Epirubicin—pancreatic cancer	0.000155	0.000163	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—GLP1R—pancreatic cancer	0.000155	0.00321	CbGpPWpGaD
Pregabalin—Haemoglobin—Doxorubicin—pancreatic cancer	0.000155	0.000163	CcSEcCtD
Pregabalin—Headache—Gemcitabine—pancreatic cancer	0.000155	0.000163	CcSEcCtD
Pregabalin—Flushing—Epirubicin—pancreatic cancer	0.000155	0.000163	CcSEcCtD
Pregabalin—Cardiac disorder—Epirubicin—pancreatic cancer	0.000155	0.000163	CcSEcCtD
Pregabalin—Vomiting—Fluorouracil—pancreatic cancer	0.000155	0.000163	CcSEcCtD
Pregabalin—Rhinitis—Doxorubicin—pancreatic cancer	0.000155	0.000163	CcSEcCtD
Pregabalin—Hepatitis—Doxorubicin—pancreatic cancer	0.000154	0.000162	CcSEcCtD
Pregabalin—Haemorrhage—Doxorubicin—pancreatic cancer	0.000154	0.000162	CcSEcCtD
Pregabalin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000153	0.000161	CcSEcCtD
Pregabalin—Rash—Fluorouracil—pancreatic cancer	0.000153	0.000161	CcSEcCtD
Pregabalin—Dermatitis—Fluorouracil—pancreatic cancer	0.000153	0.000161	CcSEcCtD
Pregabalin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000153	0.000161	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—DPYD—pancreatic cancer	0.000153	0.00316	CbGpPWpGaD
Pregabalin—Decreased appetite—Docetaxel—pancreatic cancer	0.000153	0.00016	CcSEcCtD
Pregabalin—Headache—Fluorouracil—pancreatic cancer	0.000152	0.00016	CcSEcCtD
Pregabalin—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000152	0.00016	CcSEcCtD
Pregabalin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000152	0.00016	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000152	0.000159	CcSEcCtD
Pregabalin—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000152	0.000159	CcSEcCtD
Pregabalin—Fatigue—Docetaxel—pancreatic cancer	0.000151	0.000159	CcSEcCtD
Pregabalin—Angiopathy—Epirubicin—pancreatic cancer	0.000151	0.000159	CcSEcCtD
Pregabalin—Urethral disorder—Doxorubicin—pancreatic cancer	0.000151	0.000159	CcSEcCtD
Pregabalin—Nausea—Irinotecan—pancreatic cancer	0.000151	0.000159	CcSEcCtD
Pregabalin—Immune system disorder—Epirubicin—pancreatic cancer	0.000151	0.000158	CcSEcCtD
Pregabalin—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00015	0.000158	CcSEcCtD
Pregabalin—Pain—Docetaxel—pancreatic cancer	0.00015	0.000158	CcSEcCtD
Pregabalin—Constipation—Docetaxel—pancreatic cancer	0.00015	0.000158	CcSEcCtD
Pregabalin—Chills—Epirubicin—pancreatic cancer	0.00015	0.000157	CcSEcCtD
Pregabalin—Arrhythmia—Epirubicin—pancreatic cancer	0.000149	0.000156	CcSEcCtD
Pregabalin—Visual impairment—Doxorubicin—pancreatic cancer	0.000149	0.000156	CcSEcCtD
Pregabalin—Alopecia—Epirubicin—pancreatic cancer	0.000147	0.000155	CcSEcCtD
Pregabalin—Nausea—Gemcitabine—pancreatic cancer	0.000147	0.000154	CcSEcCtD
Pregabalin—Mental disorder—Epirubicin—pancreatic cancer	0.000146	0.000153	CcSEcCtD
Pregabalin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000146	0.000153	CcSEcCtD
Pregabalin—Malnutrition—Epirubicin—pancreatic cancer	0.000145	0.000152	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—SLC2A2—pancreatic cancer	0.000145	0.003	CbGpPWpGaD
Pregabalin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000145	0.000152	CcSEcCtD
Pregabalin—Nausea—Fluorouracil—pancreatic cancer	0.000145	0.000152	CcSEcCtD
Pregabalin—Eye disorder—Doxorubicin—pancreatic cancer	0.000144	0.000151	CcSEcCtD
Pregabalin—Tinnitus—Doxorubicin—pancreatic cancer	0.000144	0.000151	CcSEcCtD
Pregabalin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000144	0.000151	CcSEcCtD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000143	0.00296	CbGpPWpGaD
Pregabalin—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000143	0.00015	CcSEcCtD
Pregabalin—Flushing—Doxorubicin—pancreatic cancer	0.000143	0.00015	CcSEcCtD
Pregabalin—Flatulence—Epirubicin—pancreatic cancer	0.000143	0.00015	CcSEcCtD
Pregabalin—Tension—Epirubicin—pancreatic cancer	0.000142	0.00015	CcSEcCtD
Pregabalin—Dysgeusia—Epirubicin—pancreatic cancer	0.000142	0.000149	CcSEcCtD
Pregabalin—Nervousness—Epirubicin—pancreatic cancer	0.000141	0.000148	CcSEcCtD
Pregabalin—Back pain—Epirubicin—pancreatic cancer	0.00014	0.000148	CcSEcCtD
Pregabalin—Angiopathy—Doxorubicin—pancreatic cancer	0.00014	0.000147	CcSEcCtD
Pregabalin—Muscle spasms—Epirubicin—pancreatic cancer	0.00014	0.000147	CcSEcCtD
Pregabalin—Immune system disorder—Doxorubicin—pancreatic cancer	0.000139	0.000146	CcSEcCtD
Pregabalin—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000139	0.000146	CcSEcCtD
Pregabalin—Body temperature increased—Docetaxel—pancreatic cancer	0.000139	0.000146	CcSEcCtD
Pregabalin—Abdominal pain—Docetaxel—pancreatic cancer	0.000139	0.000146	CcSEcCtD
Pregabalin—Chills—Doxorubicin—pancreatic cancer	0.000138	0.000145	CcSEcCtD
Pregabalin—Arrhythmia—Doxorubicin—pancreatic cancer	0.000138	0.000145	CcSEcCtD
Pregabalin—Vision blurred—Epirubicin—pancreatic cancer	0.000137	0.000144	CcSEcCtD
Pregabalin—Alopecia—Doxorubicin—pancreatic cancer	0.000136	0.000143	CcSEcCtD
Pregabalin—Mental disorder—Doxorubicin—pancreatic cancer	0.000135	0.000142	CcSEcCtD
Pregabalin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000135	0.000141	CcSEcCtD
Pregabalin—Malnutrition—Doxorubicin—pancreatic cancer	0.000134	0.000141	CcSEcCtD
Pregabalin—Anaemia—Epirubicin—pancreatic cancer	0.000134	0.000141	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—CD44—pancreatic cancer	0.000134	0.00277	CbGpPWpGaD
Pregabalin—Agitation—Epirubicin—pancreatic cancer	0.000133	0.00014	CcSEcCtD
Pregabalin—Flatulence—Doxorubicin—pancreatic cancer	0.000132	0.000139	CcSEcCtD
Pregabalin—Tension—Doxorubicin—pancreatic cancer	0.000132	0.000138	CcSEcCtD
Pregabalin—Dysgeusia—Doxorubicin—pancreatic cancer	0.000131	0.000138	CcSEcCtD
Pregabalin—CACNA1A—Neuronal System—HRAS—pancreatic cancer	0.000131	0.00271	CbGpPWpGaD
Pregabalin—Malaise—Epirubicin—pancreatic cancer	0.000131	0.000138	CcSEcCtD
Pregabalin—Nervousness—Doxorubicin—pancreatic cancer	0.00013	0.000137	CcSEcCtD
Pregabalin—Vertigo—Epirubicin—pancreatic cancer	0.00013	0.000137	CcSEcCtD
Pregabalin—Syncope—Epirubicin—pancreatic cancer	0.00013	0.000137	CcSEcCtD
Pregabalin—Leukopenia—Epirubicin—pancreatic cancer	0.00013	0.000137	CcSEcCtD
Pregabalin—Back pain—Doxorubicin—pancreatic cancer	0.00013	0.000136	CcSEcCtD
Pregabalin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000129	0.000136	CcSEcCtD
Pregabalin—Muscle spasms—Doxorubicin—pancreatic cancer	0.000129	0.000136	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—GCG—pancreatic cancer	0.000129	0.00266	CbGpPWpGaD
Pregabalin—Palpitations—Epirubicin—pancreatic cancer	0.000128	0.000135	CcSEcCtD
Pregabalin—Loss of consciousness—Epirubicin—pancreatic cancer	0.000128	0.000134	CcSEcCtD
Pregabalin—Cough—Epirubicin—pancreatic cancer	0.000127	0.000133	CcSEcCtD
Pregabalin—Vision blurred—Doxorubicin—pancreatic cancer	0.000127	0.000133	CcSEcCtD
Pregabalin—Asthenia—Docetaxel—pancreatic cancer	0.000126	0.000132	CcSEcCtD
Pregabalin—Convulsion—Epirubicin—pancreatic cancer	0.000126	0.000132	CcSEcCtD
Pregabalin—Hypertension—Epirubicin—pancreatic cancer	0.000125	0.000132	CcSEcCtD
Pregabalin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000125	0.000131	CcSEcCtD
Pregabalin—Pruritus—Docetaxel—pancreatic cancer	0.000124	0.000131	CcSEcCtD
Pregabalin—Anaemia—Doxorubicin—pancreatic cancer	0.000124	0.00013	CcSEcCtD
Pregabalin—Arthralgia—Epirubicin—pancreatic cancer	0.000124	0.00013	CcSEcCtD
Pregabalin—Chest pain—Epirubicin—pancreatic cancer	0.000124	0.00013	CcSEcCtD
Pregabalin—Myalgia—Epirubicin—pancreatic cancer	0.000124	0.00013	CcSEcCtD
Pregabalin—Agitation—Doxorubicin—pancreatic cancer	0.000123	0.00013	CcSEcCtD
Pregabalin—Anxiety—Epirubicin—pancreatic cancer	0.000123	0.000129	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000123	0.000129	CcSEcCtD
Pregabalin—Discomfort—Epirubicin—pancreatic cancer	0.000122	0.000128	CcSEcCtD
Pregabalin—Malaise—Doxorubicin—pancreatic cancer	0.000121	0.000127	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—STK11—pancreatic cancer	0.000121	0.0025	CbGpPWpGaD
Pregabalin—Dry mouth—Epirubicin—pancreatic cancer	0.000121	0.000127	CcSEcCtD
Pregabalin—Vertigo—Doxorubicin—pancreatic cancer	0.000121	0.000127	CcSEcCtD
Pregabalin—Syncope—Doxorubicin—pancreatic cancer	0.00012	0.000127	CcSEcCtD
Pregabalin—Leukopenia—Doxorubicin—pancreatic cancer	0.00012	0.000126	CcSEcCtD
Pregabalin—Diarrhoea—Docetaxel—pancreatic cancer	0.00012	0.000126	CcSEcCtD
Pregabalin—Confusional state—Epirubicin—pancreatic cancer	0.000119	0.000125	CcSEcCtD
Pregabalin—Palpitations—Doxorubicin—pancreatic cancer	0.000119	0.000125	CcSEcCtD
Pregabalin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000118	0.000124	CcSEcCtD
Pregabalin—Oedema—Epirubicin—pancreatic cancer	0.000118	0.000124	CcSEcCtD
Pregabalin—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000118	0.000124	CcSEcCtD
Pregabalin—Infection—Epirubicin—pancreatic cancer	0.000118	0.000124	CcSEcCtD
Pregabalin—Cough—Doxorubicin—pancreatic cancer	0.000117	0.000123	CcSEcCtD
Pregabalin—Shock—Epirubicin—pancreatic cancer	0.000117	0.000122	CcSEcCtD
Pregabalin—Convulsion—Doxorubicin—pancreatic cancer	0.000116	0.000122	CcSEcCtD
Pregabalin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000116	0.000122	CcSEcCtD
Pregabalin—Dizziness—Docetaxel—pancreatic cancer	0.000116	0.000122	CcSEcCtD
Pregabalin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000116	0.000122	CcSEcCtD
Pregabalin—Hypertension—Doxorubicin—pancreatic cancer	0.000116	0.000122	CcSEcCtD
Pregabalin—Tachycardia—Epirubicin—pancreatic cancer	0.000116	0.000121	CcSEcCtD
Pregabalin—Skin disorder—Epirubicin—pancreatic cancer	0.000115	0.000121	CcSEcCtD
Pregabalin—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000114	0.00012	CcSEcCtD
Pregabalin—Arthralgia—Doxorubicin—pancreatic cancer	0.000114	0.00012	CcSEcCtD
Pregabalin—Chest pain—Doxorubicin—pancreatic cancer	0.000114	0.00012	CcSEcCtD
Pregabalin—Myalgia—Doxorubicin—pancreatic cancer	0.000114	0.00012	CcSEcCtD
Pregabalin—Anxiety—Doxorubicin—pancreatic cancer	0.000114	0.00012	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000114	0.000119	CcSEcCtD
Pregabalin—Discomfort—Doxorubicin—pancreatic cancer	0.000113	0.000119	CcSEcCtD
Pregabalin—Anorexia—Epirubicin—pancreatic cancer	0.000113	0.000119	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—CD44—pancreatic cancer	0.000112	0.00232	CbGpPWpGaD
Pregabalin—Dry mouth—Doxorubicin—pancreatic cancer	0.000112	0.000117	CcSEcCtD
Pregabalin—Vomiting—Docetaxel—pancreatic cancer	0.000112	0.000117	CcSEcCtD
Pregabalin—Rash—Docetaxel—pancreatic cancer	0.000111	0.000116	CcSEcCtD
Pregabalin—Hypotension—Epirubicin—pancreatic cancer	0.000111	0.000116	CcSEcCtD
Pregabalin—Dermatitis—Docetaxel—pancreatic cancer	0.000111	0.000116	CcSEcCtD
Pregabalin—Confusional state—Doxorubicin—pancreatic cancer	0.00011	0.000116	CcSEcCtD
Pregabalin—Headache—Docetaxel—pancreatic cancer	0.00011	0.000116	CcSEcCtD
Pregabalin—CACNA2D2—Neuronal System—HRAS—pancreatic cancer	0.00011	0.00227	CbGpPWpGaD
Pregabalin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00011	0.000115	CcSEcCtD
Pregabalin—Oedema—Doxorubicin—pancreatic cancer	0.00011	0.000115	CcSEcCtD
Pregabalin—Infection—Doxorubicin—pancreatic cancer	0.000109	0.000114	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000108	0.000113	CcSEcCtD
Pregabalin—Shock—Doxorubicin—pancreatic cancer	0.000108	0.000113	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—GCG—pancreatic cancer	0.000108	0.00223	CbGpPWpGaD
Pregabalin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000107	0.000113	CcSEcCtD
Pregabalin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000107	0.000113	CcSEcCtD
Pregabalin—Insomnia—Epirubicin—pancreatic cancer	0.000107	0.000113	CcSEcCtD
Pregabalin—Tachycardia—Doxorubicin—pancreatic cancer	0.000107	0.000112	CcSEcCtD
Pregabalin—Skin disorder—Doxorubicin—pancreatic cancer	0.000106	0.000112	CcSEcCtD
Pregabalin—Paraesthesia—Epirubicin—pancreatic cancer	0.000106	0.000112	CcSEcCtD
Pregabalin—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000106	0.000111	CcSEcCtD
Pregabalin—Dyspnoea—Epirubicin—pancreatic cancer	0.000106	0.000111	CcSEcCtD
Pregabalin—Somnolence—Epirubicin—pancreatic cancer	0.000105	0.000111	CcSEcCtD
Pregabalin—Anorexia—Doxorubicin—pancreatic cancer	0.000104	0.00011	CcSEcCtD
Pregabalin—Nausea—Docetaxel—pancreatic cancer	0.000104	0.00011	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—TYMS—pancreatic cancer	0.000104	0.00215	CbGpPWpGaD
Pregabalin—Decreased appetite—Epirubicin—pancreatic cancer	0.000103	0.000108	CcSEcCtD
Pregabalin—Hypotension—Doxorubicin—pancreatic cancer	0.000102	0.000108	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000102	0.000107	CcSEcCtD
Pregabalin—Fatigue—Epirubicin—pancreatic cancer	0.000102	0.000107	CcSEcCtD
Pregabalin—Pain—Epirubicin—pancreatic cancer	0.000101	0.000106	CcSEcCtD
Pregabalin—Constipation—Epirubicin—pancreatic cancer	0.000101	0.000106	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—STK11—pancreatic cancer	0.000101	0.00209	CbGpPWpGaD
Pregabalin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	9.98e-05	0.000105	CcSEcCtD
Pregabalin—Insomnia—Doxorubicin—pancreatic cancer	9.91e-05	0.000104	CcSEcCtD
Pregabalin—Paraesthesia—Doxorubicin—pancreatic cancer	9.84e-05	0.000103	CcSEcCtD
Pregabalin—Dyspnoea—Doxorubicin—pancreatic cancer	9.77e-05	0.000103	CcSEcCtD
Pregabalin—Feeling abnormal—Epirubicin—pancreatic cancer	9.76e-05	0.000103	CcSEcCtD
Pregabalin—Somnolence—Doxorubicin—pancreatic cancer	9.74e-05	0.000102	CcSEcCtD
Pregabalin—Gastrointestinal pain—Epirubicin—pancreatic cancer	9.69e-05	0.000102	CcSEcCtD
Pregabalin—Decreased appetite—Doxorubicin—pancreatic cancer	9.53e-05	0.0001	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	9.46e-05	9.94e-05	CcSEcCtD
Pregabalin—Fatigue—Doxorubicin—pancreatic cancer	9.45e-05	9.93e-05	CcSEcCtD
Pregabalin—Urticaria—Epirubicin—pancreatic cancer	9.41e-05	9.89e-05	CcSEcCtD
Pregabalin—Pain—Doxorubicin—pancreatic cancer	9.37e-05	9.85e-05	CcSEcCtD
Pregabalin—Constipation—Doxorubicin—pancreatic cancer	9.37e-05	9.85e-05	CcSEcCtD
Pregabalin—Abdominal pain—Epirubicin—pancreatic cancer	9.36e-05	9.84e-05	CcSEcCtD
Pregabalin—Body temperature increased—Epirubicin—pancreatic cancer	9.36e-05	9.84e-05	CcSEcCtD
Pregabalin—Feeling abnormal—Doxorubicin—pancreatic cancer	9.03e-05	9.49e-05	CcSEcCtD
Pregabalin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	8.96e-05	9.42e-05	CcSEcCtD
Pregabalin—Hypersensitivity—Epirubicin—pancreatic cancer	8.73e-05	9.17e-05	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—TYMS—pancreatic cancer	8.71e-05	0.0018	CbGpPWpGaD
Pregabalin—Urticaria—Doxorubicin—pancreatic cancer	8.71e-05	9.15e-05	CcSEcCtD
Pregabalin—Body temperature increased—Doxorubicin—pancreatic cancer	8.66e-05	9.1e-05	CcSEcCtD
Pregabalin—Abdominal pain—Doxorubicin—pancreatic cancer	8.66e-05	9.1e-05	CcSEcCtD
Pregabalin—Asthenia—Epirubicin—pancreatic cancer	8.5e-05	8.93e-05	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—APOE—pancreatic cancer	8.46e-05	0.00175	CbGpPWpGaD
Pregabalin—Pruritus—Epirubicin—pancreatic cancer	8.38e-05	8.81e-05	CcSEcCtD
Pregabalin—Diarrhoea—Epirubicin—pancreatic cancer	8.1e-05	8.52e-05	CcSEcCtD
Pregabalin—Hypersensitivity—Doxorubicin—pancreatic cancer	8.07e-05	8.48e-05	CcSEcCtD
Pregabalin—Asthenia—Doxorubicin—pancreatic cancer	7.86e-05	8.26e-05	CcSEcCtD
Pregabalin—Dizziness—Epirubicin—pancreatic cancer	7.83e-05	8.23e-05	CcSEcCtD
Pregabalin—Pruritus—Doxorubicin—pancreatic cancer	7.75e-05	8.15e-05	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—PIK3CG—pancreatic cancer	7.63e-05	0.00158	CbGpPWpGaD
Pregabalin—Vomiting—Epirubicin—pancreatic cancer	7.53e-05	7.91e-05	CcSEcCtD
Pregabalin—Diarrhoea—Doxorubicin—pancreatic cancer	7.5e-05	7.88e-05	CcSEcCtD
Pregabalin—Rash—Epirubicin—pancreatic cancer	7.47e-05	7.85e-05	CcSEcCtD
Pregabalin—Dermatitis—Epirubicin—pancreatic cancer	7.46e-05	7.84e-05	CcSEcCtD
Pregabalin—Headache—Epirubicin—pancreatic cancer	7.42e-05	7.8e-05	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—PPARG—pancreatic cancer	7.36e-05	0.00152	CbGpPWpGaD
Pregabalin—Dizziness—Doxorubicin—pancreatic cancer	7.25e-05	7.62e-05	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—APOE—pancreatic cancer	7.09e-05	0.00146	CbGpPWpGaD
Pregabalin—Nausea—Epirubicin—pancreatic cancer	7.04e-05	7.39e-05	CcSEcCtD
Pregabalin—Vomiting—Doxorubicin—pancreatic cancer	6.97e-05	7.32e-05	CcSEcCtD
Pregabalin—Rash—Doxorubicin—pancreatic cancer	6.91e-05	7.26e-05	CcSEcCtD
Pregabalin—Dermatitis—Doxorubicin—pancreatic cancer	6.9e-05	7.25e-05	CcSEcCtD
Pregabalin—Headache—Doxorubicin—pancreatic cancer	6.87e-05	7.21e-05	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—PIK3CD—pancreatic cancer	6.71e-05	0.00139	CbGpPWpGaD
Pregabalin—Nausea—Doxorubicin—pancreatic cancer	6.51e-05	6.84e-05	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—PIK3CG—pancreatic cancer	6.39e-05	0.00132	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PPARG—pancreatic cancer	6.17e-05	0.00128	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PIK3CB—pancreatic cancer	5.85e-05	0.00121	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PTGS2—pancreatic cancer	5.79e-05	0.0012	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PIK3CD—pancreatic cancer	5.62e-05	0.00116	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PTEN—pancreatic cancer	5.05e-05	0.00104	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PIK3CB—pancreatic cancer	4.9e-05	0.00101	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PTGS2—pancreatic cancer	4.85e-05	0.001	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PTEN—pancreatic cancer	4.23e-05	0.000875	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PIK3CA—pancreatic cancer	3.56e-05	0.000737	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PIK3CA—pancreatic cancer	2.99e-05	0.000618	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—AKT1—pancreatic cancer	2.91e-05	0.000602	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—AKT1—pancreatic cancer	2.44e-05	0.000504	CbGpPWpGaD
